Privium Fund Management B.V.
Filing Date
Global Rank
#2,654
/ 8,603
▼ 120
· as of Mar 2026
Top Industry
Biotechnology
29.6%
3Y Alpha vs SPY
+7.7%
Period ended 3 months ago
Filed May 5, 2026 · 2mo
18 quarters · since Dec 2021
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+110.8%
SPY
+76.0%
Annualised alpha
+7.5%
Max drawdown
−31.0%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
59 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
17.2%
−1.7 pts
Top 5
45.5%
−4.5 pts
Top 10
64.0%
−4.2 pts
HHI
635
Diversified−110
Portfolio Trend
18 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 33.9% | $162,565,249 |
| Consumer Cyclical | 25.0% | $119,990,030 |
| Technology | 24.2% | $116,289,550 |
| Financial Services | 8.5% | $40,768,566 |
| Communication Services | 6.8% | $32,488,970 |
| Energy | 0.8% | $3,872,370 |
| Consumer Defensive | 0.6% | $2,769,789 |
| Basic Materials | 0.3% | $1,353,722 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
24 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PRQR | ProQR Therapeutics N.V. | +109,387 | 5,467,149 | $8,856,781 | |
| RCKT | Rocket Pharmaceuticals, Inc. | +72,000 | 242,146 | $866,882 | |
| QURE | uniQure N.V. | +70,250 | 486,520 | $7,954,602 | |
| IONS | Ionis Pharmaceuticals Inc | +49,200 | 290,024 | $21,777,902 | |
| WVE | Wave Life Sciences Ltd. | +48,000 | 241,010 | $1,747,322 | |
| FATE | Fate Therapeutics Inc | +45,211 | 414,311 | $497,173 | |
| IREN | IREN Ltd | +40,150 | 320,150 | $10,974,742 | |
| AUTL | Autolus Therapeutics plc | +37,185 | 363,430 | $501,533 | |
| VYGR | Voyager Therapeutics, Inc. | +25,000 | 120,000 | $463,200 | |
| URGN | UroGen Pharma Ltd. | +23,500 | 238,122 | $4,281,433 | |
| TSHA | Taysha Gene Therapies, Inc. | +17,000 | 181,900 | $813,093 | |
| ARQT | Arcutis Biotherapeutics, Inc. | +15,000 | 320,972 | $7,562,100 | |
| PFE | Pfizer Inc | +14,929 | 52,679 | $1,479,226 | |
| LXEO | Lexeo Therapeutics, Inc. | +12,450 | 205,000 | $1,176,700 | |
| MGTX | MeiraGTx Holdings plc | +12,112 | 212,112 | $1,836,889 | |
| RARE | Ultragenyx Pharmaceutical Inc. | +7,300 | 364,802 | $7,642,601 | |
| LMND | Lemonade, Inc. | +7,000 | 255,259 | $15,999,634 | |
| RNAC | Cartesian Therapeutics, Inc. | +6,614 | 179,114 | $1,101,551 | |
| AMZN | Amazon Com Inc | +4,000 | 125,000 | $26,033,750 | |
| SRPT | Sarepta Therapeutics, Inc. | +3,000 | 46,000 | $1,000,960 | |
| AMD | Advanced Micro Devices Inc | +2,000 | 62,000 | $12,612,660 | |
| VRTX | Vertex Pharmaceuticals Inc / Ma | +2,000 | 11,355 | $5,070,461 | |
| AXSM | Axsome Therapeutics, Inc. | +1,851 | 58,729 | $9,926,375 | |
| SA | Seabridge Gold Inc | +1,072 | 24,828 | $703,625 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
16 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ABEV | Ambev S.A. | −114,616 | 948,558 | $2,769,789 | |
| FDMT | 4D Molecular Therapeutics, Inc. | −39,744 | 170,256 | $1,585,083 | |
| RIG | Transocean Ltd. | −33,000 | 106,604 | $706,784 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | −31,268 | 366,936 | $23,006,887 | |
| BIIB | Biogen Inc. | −29,680 | 43,800 | $8,029,854 | |
| SLB | Slb Limited/Nv | −20,354 | 18,451 | $948,196 | |
| MRNA | Moderna, Inc. | −19,600 | 29,994 | $1,523,695 | |
| NOV | NOV Inc. | −11,100 | 42,026 | $790,509 | |
| BEAM | Beam Therapeutics Inc. | −7,518 | 63,982 | $1,524,691 | |
| TSLA | Tesla, Inc. | −6,500 | 222,000 | $82,528,500 | |
| BNTX | BioNTech SE | −6,300 | 27,000 | $2,399,760 | |
| STOK | Stoke Therapeutics, Inc. | −5,000 | 50,000 | $1,628,000 | |
| NE | Noble Corp plc | −4,000 | 6,849 | $336,080 | |
| SHOP | Shopify Inc. | −3,000 | 407,000 | $48,278,340 | |
| SPOT | Spotify Technology S.A. | −1,000 | 67,000 | $32,488,970 | |
| KRYS | Krystal Biotech, Inc. | −1,000 | 11,170 | $2,885,434 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
7 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ESPR | Esperion Therapeutics, Inc. | 3,299,441 | $9,040,468 | |
| BMRN | Biomarin Pharmaceutical Inc | 92,305 | $5,214,309 | |
| DNLI | Denali Therapeutics Inc. | 254,857 | $4,893,254 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 12,222 | $4,043,893 | |
| MOH | Molina Healthcare, Inc. | 8,140 | $1,085,062 | |
| BTG | B2gold Corp | 96,477 | $437,040 | |
| PAAS | Pan American Silver Corp | 3,900 | $213,057 | |
| No positions match the current search. | ||||
59 positions ·
$480,098,246 total
· as of Mar 31, 2026
All sectors
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Technology
Showing 1–50
of 59 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| TSLA |
Tesla, Inc.
Consumer Cyclical
|
Reduced | 222,000 | $82,528,500 | 17.19% | |
| SHOP |
Shopify Inc.
Technology
|
Reduced | 407,000 | $48,278,340 | 10.06% | |
| SPOT |
Spotify Technology S.A.
Communication Services
|
Reduced | 67,000 | $32,488,970 | 6.77% | |
| PLTR |
Palantir Technologies Inc.
Technology
|
Held | 200,000 | $29,256,000 | 6.09% | |
| AMZN |
Amazon Com Inc
Consumer Cyclical
|
Added | 125,000 | $26,033,750 | 5.42% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
Reduced | 366,936 | $23,006,887 | 4.79% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Added | 290,024 | $21,777,902 | 4.54% | |
| LMND |
Lemonade, Inc.
Financial Services
|
Added | 255,259 | $15,999,634 | 3.33% | |
| NVDA |
Nvidia Corp
Technology
|
Held | 81,000 | $14,126,400 | 2.94% | |
| COIN |
Coinbase Global, Inc.
Financial Services
|
Held | 79,000 | $13,794,190 | 2.87% | |
| AMD |
Advanced Micro Devices Inc
Technology
|
Added | 62,000 | $12,612,660 | 2.63% | |
| ASTS |
AST SpaceMobile, Inc.
Technology
|
Held | 145,000 | $12,016,150 | 2.50% | |
| SE |
Sea Ltd
Consumer Cyclical
|
Held | 138,000 | $11,427,780 | 2.38% | |
| IREN |
IREN Ltd
Financial Services
|
Added | 320,150 | $10,974,742 | 2.29% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Added | 58,729 | $9,926,375 | 2.07% | |
| ESPR |
Esperion Therapeutics, Inc.
Healthcare
|
NEW | 3,299,441 | $9,040,468 | 1.88% | |
| PRQR |
ProQR Therapeutics N.V.
Healthcare
|
Added | 5,467,149 | $8,856,781 | 1.84% | |
| BIIB |
Biogen Inc.
Healthcare
|
Reduced | 43,800 | $8,029,854 | 1.67% | |
| QURE |
uniQure N.V.
Healthcare
|
Added | 486,520 | $7,954,602 | 1.66% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Added | 364,802 | $7,642,601 | 1.59% | |
| ARQT |
Arcutis Biotherapeutics, Inc.
Healthcare
|
Added | 320,972 | $7,562,100 | 1.58% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
NEW | 92,305 | $5,214,309 | 1.09% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
Added | 11,355 | $5,070,461 | 1.06% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
NEW | 254,857 | $4,893,254 | 1.02% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
Added | 238,122 | $4,281,433 | 0.89% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
NEW | 12,222 | $4,043,893 | 0.84% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Held | 173,516 | $3,393,972 | 0.71% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
Reduced | 11,170 | $2,885,434 | 0.60% | |
| ABEV |
Ambev S.A.
Consumer Defensive
|
Reduced | 948,558 | $2,769,789 | 0.58% | |
| ZLAB |
Zai Lab Ltd
Healthcare
|
Held | 132,189 | $2,486,475 | 0.52% | |
| BNTX |
BioNTech SE
Healthcare
|
Reduced | 27,000 | $2,399,760 | 0.50% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
Held | 352,087 | $2,397,712 | 0.50% | |
| CRSP |
CRISPR Therapeutics AG
Healthcare
|
Held | 42,874 | $2,039,516 | 0.42% | |
| MGTX |
MeiraGTx Holdings plc
Healthcare
|
Added | 212,112 | $1,836,889 | 0.38% | |
| WVE |
Wave Life Sciences Ltd.
Healthcare
|
Added | 241,010 | $1,747,322 | 0.36% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
Reduced | 50,000 | $1,628,000 | 0.34% | |
| FDMT |
4D Molecular Therapeutics, Inc.
Healthcare
|
Reduced | 170,256 | $1,585,083 | 0.33% | |
| BEAM |
Beam Therapeutics Inc.
Healthcare
|
Reduced | 63,982 | $1,524,691 | 0.32% | |
| MRNA |
Moderna, Inc.
Healthcare
|
Reduced | 29,994 | $1,523,695 | 0.32% | |
| PFE |
Pfizer Inc
Healthcare
|
Added | 52,679 | $1,479,226 | 0.31% | |
| LXEO |
Lexeo Therapeutics, Inc.
Healthcare
|
Added | 205,000 | $1,176,700 | 0.25% | |
| RNAC |
Cartesian Therapeutics, Inc.
Healthcare
|
Added | 179,114 | $1,101,551 | 0.23% | |
| MOH |
Molina Healthcare, Inc.
Healthcare
|
NEW | 8,140 | $1,085,062 | 0.23% | |
| SRPT |
Sarepta Therapeutics, Inc.
Healthcare
|
Added | 46,000 | $1,000,960 | 0.21% | |
| SLB |
Slb Limited/Nv
Energy
|
Reduced | 18,451 | $948,196 | 0.20% | |
| RCKT |
Rocket Pharmaceuticals, Inc.
Healthcare
|
Added | 242,146 | $866,882 | 0.18% | |
| HIMS |
Hims & Hers Health, Inc.
Healthcare
|
Held | 40,000 | $830,400 | 0.17% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Added | 181,900 | $813,093 | 0.17% | |
| NOV |
NOV Inc.
Energy
|
Reduced | 42,026 | $790,509 | 0.16% | |
| RIG |
Transocean Ltd.
Energy
|
Reduced | 106,604 | $706,784 | 0.15% |